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Crystal Structure of an MHC Class I
Presented Glycopeptide that Generates
Carbohydrate-Specific CTL
TCR binds the pMHC surface in a diagonal orientation in
which a majority of the intermolecular interactions are
derived from contact of CDRs 1 and 2 of both TCR
polypeptide chains with highly conserved MHC a1 and
a2 helical residues. The TCR a and b chain hypervariable
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CDR3 loops are ideally positioned within the MHC heli-10550 North Torrey Pines Road
ces to examine the contents of the peptide bindingLa Jolla, California 92037
groove and hence are well suited for their role in peptide-³Microbiology and Tumorbiology Center
antigen recognition. The consistent diagonal orientationKarolinska Institutet
of the TCRs over the pMHC so far observed allows moreP.O. Box 280
accurate prediction of the structural determinants ofS-171 77 Stockholm
MHC-bound ligands that are likely to be responsible forSweden
T cell recognition (reviewed by Wilson and Garcia, 1997).
The biological role of antigen ligation by g/d TCR in
T cell±mediated immunity is far less understood. Indeed,Summary
MHC-independent recognition of ligands by g/d TCRs
was anticipated after analysis of their primary struc-T cell receptor (TCR) recognition of nonpeptidic and
tures. Similar to the comparison between immunoglobinmodified peptide antigens has been recently uncov-
(Ig) VH and VL CDR3 loops, the TCR d chain CDR3s areered but is still poorly understood. Immunization with
significantly longer and more heterogenous in lengthan H-2Kb-restricted glycopeptide RGY8-6H-Gal2 gen- than those of the g chain (Rock et al., 1994). The TCRerates a population of cytotoxic T cells that express
a and b chain CDR3s are both long and homogeneousboth a/b TCR, specific for glycopeptide, and g/d TCR,
in length. Therefore, the g and d chain pairings suggestspecific for the disaccharide, even on glycolipids. The
g/d TCR antigen binding is more closely related to thatcrystal structure of Kb/RGY8-6H-Gal2 now demon- of Ig molecules than to a/b TCR (Rock et al., 1994; Davisstrates that the peptide and H-2Kb structures are unaf-
and Chien, 1995). Many g/d T cell effector functionsfected by the peptide glycosylation, but the central
overlap with those of a/b T cells; however, g/d T cellsregion of the putative TCR binding site is dominated by
differ in their antigens and mode of ligand recognition
the extensive exposure of the tethered carbohydrate.
that may be reflected in their localization, relative popu-
These features of the Kb/RGY8-6H-Gal2 structure are lation, and activation kinetics (Kaufmann, 1996; Bois-
consistent with the individual ligand binding prefer-
menu and Havran, 1997).
ences identified for the a/b and g/d TCRs and thus
Glycosylation is a common posttranslational modifi-
explain the generation of a carbohydrate-specific T cation of proteins to be secreted or transported to the
cell response. cell surface (Varki, 1993). Nevertheless, evidence for the
processing of glycoproteins to glycopeptides and sub-
Introduction sequent glycopeptide presentation by MHC class I
(MHC I) or II (MHC II) receptors during normal immune
The dogma of exclusive T cell recognition of peptide- responses is scarce (Carbone and Gleeson, 1997; Kihl-
major histocompatibility complex (pMHC) antigens has berg and Elofsson, 1997). Glycosylated fragments of
recently been challenged (Kaufmann, 1996; Melian et collagen type II presented by MHC II I-Aq (Broddefalk
al., 1996; Porcelli et al., 1996; Carbone and Gleeson, et al., 1998) and the O-linked glycosylation of cytosolic
1997; Kihlberg and Elofsson, 1997). Cells presenting and nuclear proteins with a single N-acetylglucosamine
nonpeptidic or modified peptide antigens (e.g., glyco- (GlcNAc) (Hart et al., 1989; Haurum et al., 1994) represent
peptides and glycolipids bound to class I and II MHC, two possible sources of natural glycopeptides for T cell
and MHC class I±like CD1 molecules, respectively) can recognition.
also be recognized by cytotoxic T cells (CTL) bearing Studies using synthetic glycopeptides have enhanced
a/b or g/d T cell receptors (TCR) (Beckman et al., 1994; our understanding of oligosaccharide recognition by T
Davis and Chien, 1995; Sieling et al., 1995; Chien et al., cells (Carbone and Gleeson, 1997; Kihlberg and Elofs-
1996; Kaufmann, 1996; reviewed by Porcelli et al., 1998). son, 1997). The ability of T cells to recognize carbohy-
However, the structural properties of these unconven- drates has important implications, as some glycoprotein
tional TCR ligands are currently undetermined except and glycolipid-associated oligosaccharides have been
for the crystal structure of mouse CD1 (Zeng et al., 1997). identified as tumor-associated antigens (TAA; Hako-
Conventional T cell recognition of pMHC has been mori, 1989). In the first demonstration of a T cell re-
widely studied (Eisen et al., 1996; Davis et al., 1998) and sponse to a naturally occuring glycan, immunization with
now includes the recent high-resolution crystal struc- synthetic MHC I restricted peptides conjugated with
tures of intact a/b TCR-pMHC complexes (Garboczi et GlcNAc generated glycopeptide-specific CTL (Haurum
al., 1996; Garcia et al., 1996, 1998; Ding et al., 1998). The et al., 1994). Although many studies have demonstrated
the fine specificity of helper T cells and CTL for glyco-
peptide versus carrier peptide, they have not convinc-§ To whom correspondence should be addressed (email: mikael.
jondal@mtc.ki.se [M. J.], wilson@scripps.edu [I. A. W.]). ingly demonstrated TCR recognition of the carbohydrate
Immunity
52
Figure 1. Glycosylated MHC I Peptide Epi-
topes and Glycolipids Tested for Carbohy-
drate-Specific T Cell Generation and Recog-
nition
(A) Sequence of glycosylated viral peptides
of H-2Db (top two) or H-2Kb (bottom two). The
amino acids replaced by chemical linkers (H,
homocysteine-ethylene; S, serine; C, cyste-
ine-ethylene) are denoted by the arrows con-
nected to the attached carbohydrates. The
term ªhomocysteineº will refer to the homo-
cysteine-ethylene linker throughout. The pri-
mary anchor residues of each peptide are
underlined. Glycopeptide names are given as
the first three amino acids of the carrier pep-
tide and its residue length, followed by the
linker position and type, then the coupled car-
bohydrate abbreviation. Thus, ASN9-4H-Gal2
is the Db nonapeptide with galabiose (Gal-
a(1,4)Gal-b) coupled to position 4 via a homo-
cysteine linker.
(B) Structures of the three types of chemical
linkers, which are conjugated with galabiose
in this illustration. The glycopeptides shown
are, from top to bottom, RGY8-6H-Gal2, ASN9-
4H-Gal2, and CRG9-1C-Gal2.
(C) Chemical structures of selected glycolip-
ids synthesized with the same carbohydrate
moieties present in the glycopeptides; they
are, from top to bottom, Gal2-bisulfone, CD77-
bisulfone, Lactose-bisulfone, and GM3-lac-
tam ceramide.
hapten moiety independent of the restricting MHC back- Results
ground or carrier peptide. We have found that immuniza-
tion with MHC I H-2Kb restricted glycopeptide RGY8- Chemical Characteristics of the Glycopeptides
and Glycolipids6H-Gal2 (Figure 1) can generate polyclonal CTL that
specifically kill cells presenting the glycopeptide-MHC The known MHC allele-specific motifs (Rammensee et
al., 1995) and available crystal structures of Kb (Fremontcomplex (gpMHC) as well as a glycolipid with the galabi-
ose oligosaccharide as the hydrophilic head group et al., 1992) and Db (Young et al., 1994) were utilized
in glycopeptide synthesis and design (Figure 1). The(Abdel-Motal et al., 1996). Fractionation of the CTL pop-
ulation by TCR expression has shown glycopeptide- Db-binding peptides were ASNENMETM from PR8 influ-
enza virus nucleoprotein (NP) (van Bleek and Nathenson,specific killing is mediated by a/b T cells (60% of the
CTL), and glycolipid-specific killing by g/d T cells (10%± 1990) and SGPSNTPPEI from adenovirus Ad5EI protein
(Rammensee et al., 1993). The Kb-binding peptides were15% of the CTL). The MHC-restricted a/b T cell response
to the glycopeptide, and gpMHC-unrestricted, hapten- FAPGNYPAL from Sendai virus NP (Schumacher et al.,
1991) and RGYVYQGL from vesicular stomatitis virusspecific response of g/d T cells correlate well with the
antigen recognition abilities of each T cell subset. (VSV) NP (van Bleek and Nathenson, 1990). The allele-
specific anchor residues for Kb and Db are centrally lo-Although their biological properties have been eluci-
dated, the structures of MHC-presented glycopeptides cated at P5 for Db and P5 (8-mer) or P6 (9-mer) for Kb
(Figure 1).have not. Structural analysis is essential since a majority
of the synthetic glycopeptides that have been tested Five carbohydrates differing in size and chemical
structure were coupled either to serine, cysteine, orhave failed to generate carbohydrate-specific T cell re-
sponses (Kihlberg and Elofsson, 1997). Glycopeptides homocysteine (Figure 1). Oligosaccharide CD77 is the
Burkitt lymphoma TAA (Nudelman et al., 1983). Lactosewith centrally located oligosaccharides, such as RGY8-
6H-Gal2, have clearly been the most immunogenic (Abdel- and GM3-lactam are also tumor-associated saccharides
(Holmes et al., 1987; Nores et al., 1987). Galabiose (Gal-Motal et al., 1996). Therefore, we determined the crystal
structure of the H-2Kb/RGY8-6H-Gal2 complex at 2.2 AÊ a(1,4)-Galb or Gal2) is an integral part of several natural
glycolipid head groups and is the terminal disaccharideresolution to identify the structural determinants critical
for T cell activation. The RGY8-6H-Gal2 glycopeptide of CD77 (Figure 1). The amino acid glycans replaced
upward-pointed residues flanking the central anchor instructure shows that glycan position, linker length, and
carbohydrate size are important for recognition and dis- the Kb or Db peptides or were added to their termini
(Figure 1; Abdel-Motal et al., 1995, 1996).crimination by the different T cells and can be rational-
ized with the recently determined footprint of the a/b T Peptide binding to MHC I was unaffected by the gly-
can modifications (Abdel-Motal et al., 1996), and thecell receptor over the pMHC (Garboczi et al., 1996; Gar-
cia et al., 1996, 1998; Ding et al., 1998). stability of the glycopeptides in vivo has been previously
Structure of an MHC-Glycopeptide Complex
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Table 1. Cell Surface Carbohydrate (CHO) Exposure and Specificity of CTL Raised against Glycopeptide Immunogens
Cytotoxicityc
Peptide, Glycopeptide,
MHC Class I Immunogen or Glycolipid Antigena CHO Detectionb Whole a/b2 g/d2
Kb RGY8-4H-Gal2 RGY8-4H-Gal2 11 111
RGY8-4H 1
RGY8-6H-Gal2 RGY8-6H-Gal2 111 111 2/1 111
RGY8-6H 1
Gal2-bis sulfonlipid 111 11 11 2/1
CD77-bis sulfonlipid 111 1
GM3-lactam ceramide 111 2
Lactose-bis sulfonlipid 2
RGY8-4H-CD77 RGY8-4H-CD77 1 11
RGY8-4H 1
RGY8-4H-GM3-lactam RGY8-4H-GM3-lactam 111 11
RGY8-4H 1
Db ASN9-4H-Gal2 ASN9-4H-Gal2 11 2/1
ASN9-4H 2/1
ASN9-6H-Gal2 ASN9-6H-Gal2 111 1
ASN9-6H 1
ASN9-6H-CD77 ASN9-6H-CD77 2 2
ASN9-6H 2
The data are summarized from Abdel-Motal et al. (1996). Blank slots indicate the data are undetermined.
a See Figure 1 legend for an explanation of the glycopeptide and glycolipid nomenclature. Antigens without a carbohydrate abbreviation
represent the carrier peptide stripped of carbohydrate.
b Mean fluorescence intensity (MFI) from flow cytoflourometric analysis of glycopeptide-treated RMA-S cells or glycolipid-coated EL-4 cells.
Measurement of corresponding anti-carbohydrate MAb binding with FITC-labeled rabbit anti-mouse Ig is given on a relative logarithmic scale
from 2 to 111. The different levels are 50±100 (1), 100±250 (11), and 300±400 (111) above control background. The IgM MAb specific for
CD77 did not bind well to the trisaccharide conjugated to either peptide.
c Generated CTL were tested against peptide, glycopeptide, or glycolipid-coated EL-4 target cells as described (Abdel-Motal et al., 1996).
Killing (51Cr-release) above background is given on a scale from 2 to 111. The different levels are 1%±5% (2/1), 5%±25% (1), 25%±50%
(11), and more than 50% (111) specific target cell lysis above background. The RGY8-6h-Gal2 and Gal2-bisulfonlipid antigens were also
examined with CTL populations depleted of either a/b (a/b2) or g/d (g/d2) T cells using magnetic Dynabeads coated with specific anti-
framework MAb.
demonstrated (Abdel-Motal et al., 1993). Monoclonal an- RGY8-4H-Gal2 and RGY8-6H-Gal2, with central homo-
tibody (MAb) detection of the peptide-linked carbohy- cysteine-coupled galabiose generated strong bulk CTL
drates on the cell surface differed depending on the responses that specifically killed glycopeptide-coated
position of the glycan substitution on the peptide and target cells (Table 1; Figure 1). Fractionation of the
linker length. Thus, antibody binding to the peptide gly- RGY8-6H-Gal2 generated T cell population based on
cans provided a measure of the carbohydrate exposure a/b or g/d TCR expression determined glycopeptide-
in the various pMHC complexes. Carbohydrates attached specific killing was primarily by the a/b T cells (Table
at internal positions in the peptide by the serine linker 1). Interestingly, the bulk CTL generated with RGY8-
were poorly detected by anti-carbohydrate MAb. In con- 6H-Gal2 also killed target cells coated with Db-binding
trast, high carbohydrate exposure was detected for all of glycopeptides containing homocysteine-coupled gala-
the glycopeptides that had N-terminal cysteine-ethylene biose (e.g., ASN9-6H-Gal2), and suggested a strict car-
extensions or with the homocysteine linker at internal bohydrate specificity independent of the pMHC back-
positions with one exception (ASN9-6H-CD77, Table 1). ground (Abdel-Motal et al., 1996).
The anti-CD77 MAb is of the IgM type and may not be MHC-unrestricted carbohydrate specificity was un-
optimal for binding to CD77 in the context of the pMHC. ambiguously determined by fusing liposomes com-
Carbohydrate headgroups in all of the glycolipids, after posed of galabiose containing glycolipid (Figure 1C) with
liposomal transfer to EL-4 target cells, were highly ex- EL-4, YAC-I, and P815 cells. These glycolipid-coated
posed at the cell surface and stable for at least 24 hr target cells were specifically killed by a small g/d T cell
under tissue culture conditions, as detected with the subpopulation present in the bulk CTL generated against
corresponding anti-carbohydrate MAb (Abdel-Motal et RGY8-6H-Gal2 (Table 1). These data suggest that the
al., 1996). a/b and g/d T cells recognized different portions of the
same gpMHC antigen that correlates with their specific
Specificity of a/b and g/d CTL toward killing of glycopeptide-coated or glycolipid-coated tar-
Glycopeptides and Glycolipids get cells, respectively. Thus, we determined the H-2Kb/
Immunizations with the glycopeptide panel produced a RGY8-6H-Gal2 crystal structure to improve our under-
wide range of T cell responses (Table 1; Abdel-Motal et standing of carbohydrate recognition by T cells.
al., 1996). Glycosylation of the peptide termini, glyco-
peptides with internal serine-coupled oligosaccharides,
RGY8-6H-Gal2 Glycopeptide Structureand Db-binding glycopeptides produced low CTL re-
The crystal structure of Kb/RGY8-6H-Gal2 was deter-sponses in general with no evidence for any carbohy-
drate specificity. In contrast, Kb-binding glycopeptides, mined using well-developed procedures for Kb pMHC
Immunity
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Figure 2. Glycopeptide Electron Density in
the H-2Kb Binding Groove
(A) Shaken (McRee, 1993), sA-weighted (Read,
1986) Fo-Fc map contoured at 1.5s. The map
was computed before refinement of the gly-
copeptide model; the final coordinates col-
ored by atom type (C, yellow; O, red; N, cyan;
S, green) are shown in the electron density.
(B) Final shaken and sA-weighted 2Fo-Fc map
contoured at 1s. A 2.5 AÊ cover radius has
been applied to the density in both maps.
Atom O69 is out of view behind the terminal
galactose in this view.
complexes (see Experimental Procedures). The final peptide backbone (e.g., see ArgP1 in Figures 2 and 3).
Interestingly, there are no significant alterations of themodel included the H-2Kb/glycopeptide complex, four
well-ordered N-linked carbohydrates to the MHC, and Kb structure as a result of glycopeptide binding.
The conformation of the galabiose thioether linker108 waters (Rcryst 22.4%, Rfree 27.9%). Electron density
for RGY8-6H-Gal2 was continuous and well resolved, loosely matches that of VSV-8 GlnP6 for the first few
equivalent atom positions and orients HggP6 towardallowing unambiguous modeling of the glycosylated
peptide (Figure 2). The glycopeptide structure is nearly the a2 helix (Figure 3B). HggP6 ªleansº on the a2 helix,
creating several contacts unique to the glycopeptideidentical to that of Kb-bound VSV-8 for the common
residues (P1-P5, P7-P8) (Fremont et al., 1992). The root- (Table 2), but does not make any hydrogen bonds. In
the absence of T cell receptor ligation or any directmean-square deviation (r.m.s.d) is only 0.19 AÊ for the
equivalent polyalanine atoms between VSV-8 and RGY8- hydrogen bonds to the linker or sugars from the Kb a1a2
domains, the polar and hydrophobic contacts are the6H-Gal2 after the Ca atoms of the Kb a1a2 superdomains
are aligned. Many interactions between the glycopep- only interactions stabilizing the placement of the glyco-
sidic modification adjacent to the a2 helix.tide and MHC heavy chain, including water-mediated
hydrogen bonds, are also shared with the Kb/VSV-8 com- The contacts between the disaccharide and Kb are
mainly with the internal galactose residue. Only a singleplex (Table 2); however, the glycosidic modification
makes RGY8-6H-Gal2 the largest MHC I bound antigen contact exists between the Kb a2 domain and the termi-
nal galactose (Table 2); in fact, both sugars of the galabi-to have its structure determined to date. The homocys-
teine galabiose glycan at position 6 of the peptide ose are clasped between the MHC a2 helix and the b2m
subunit of a neighboring Kb molecule in the crystal lat-(HggP6) extends 12 AÊ above the peptide backbone (Fig-
ures 3A and 3B). Arginine, the longest unmodified amino tice. The neighboring b2m is on the opposite side of
galabiose from the a2 helix. Two hydrogen bonds andacid, can only extend approximately 7 AÊ out from the
Structure of an MHC-Glycopeptide Complex
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Table 2. Glycopeptide Interactions with H-2Kb
Glycopeptide MHC Codeb Glycopeptide MHCa Codeb
ArgP1 N Tyr7 OH P SD Glu152 OE2 V
Tyr171 OH P Glyb43 O* P
O Tyr159 OH H CD Glu152 OE2 V
NH1 Arg62 NE P CE Glyb43 C, CA, O* V
GlyP2 N Tyr7 OH P O1 Glu152 OE2 P
Glu63 OE1 H Arg155 CD V
O Lys66 NZ H Arg155 NE P
TyrP3 O Asn70 ND2 H O2 Leub40 CD2* V
Wat99-Glu24 OE2 H Glyb43 O* P
OH Glu152 OE1 H Argb81 NH1* P
Arg155 NE, NH2 P O3 Argb81 NH1* H
ValP4 O Arg155 NH1 H C5 Ala150 O V
Arg155 NH2 H O5 Arg155 CD V
TyrP5 N Asn70 OD1 H O2' Arg155 CG V
O Wat43-Asn70 OD1 H C6' Lysb83 NZ* V
Wat43-Ser73 OG H O6' Argb81 NE* P
Wat43-Wat80 H Argb81 NH1* P
OH Ser99 OG P Argb81 NH2* P
HggP6c N Arg155 NH2 P Lysb83 CE* V
O Trp147 CZ2 V Lysb83 NZ* H
Wat5-Asp77 OD1 H GlyP7 O Trp147 NE1 H
CB Glu152 CD V LeuP8 N Asp77 OD2 H
Glu152 OE1 V O Tyr84 OH H
Glu152 OE2 V Thr143 OG1 H
Arg155 NH2 V OT Wat87-Asp77 OD2 H
CG Trp147 CD1 V Wat87-Thr80 OG1 H
Trp147 NE1 V
a Residues marked with an asterisk are from the b2-microglobulin domain (b) of a neighboring molecule in the crystal.
b H, hydrogen bond; P, polar interaction; V, van der Waals interaction (only listed for HggP6). Polar interactions are defined as van der Waals
interactions between highly electronegative atoms. The distance and geometry criteria for hydrogen bonds are the defaults used in HBPLUS
(McDonald and Thornton, 1994). When a hydrogen bond is made from the glycopeptide to the MHC via a bridging water, all hydrogen bonds
from the water to the MHC are listed (e.g., Wat43). The maximum distance allowed for polar or van der Waals interactions is 4.3 AÊ .
c Hgg is the abbreviation for homocysteine galabiose glycan. Hgg, with selected atoms labeled, is shown in Figure 2.
several polar interactions between HggP6 and neigh- Modeling studies of this complex show that the galabi-
boring b2m residues Leub40, Glyb43, Argb81, and Lysb83 ose exposure could be even greater. Torsion angles
are a result of the galabiose entrapment (Table 2). These for the relatively long thioether-hydrocarbon linker are
interactions may be preventing the formation of other largely unrestricted. Small rotations (,208) of just two
hydrogen bonds between galabiose and Kb. of the linker torsion angles can free the galabiose from
The peptide-conjugated galabiose retains a structure any contact with the Kb a2 helix (Figure 3C). The reposi-
very similar to that of the free disaccharide (Svensson et tioned galabiose would be 100% solvent accessible giv-
al., 1986). Superposition of the small molecule galabiose ing the glycopeptide nearly double the exposed peptide
crystal structure with the HggP6-linked disaccharide surface area of other MHC-bound peptides (383 AÊ 2
structure gives an r.m.s.d of only 0.78 AÊ . The two galabi- versus 150±220 AÊ 2). Galabiose-specific monoclonal anti-
ose structures differ mainly due to a 468 difference be- bodies strongly recognize RGY8-6H-Gal2 treated RMA-S
tween their internal glycosidic dihedral angles, presum- cells (Abdel-Motal et al., 1996), providing further evi-
ably due to contact of the HggP6 galabiose with the dence for the high exposure of the glycopeptide-
neighboring b2m molecule; the terminal galactose in attached galabiose. The MAb could possibly recognize
HggP6 must rotate away from the neighboring b2m mole- the galabiose in close proximity to the MHC helices, but
cule to avoid forming energetically unfavorable close small haptens are more commonly buried deep within
contacts. the immunoglobin combining site (reviewed by Wilson
and Stanfield, 1994). The unrestricted access to the ga-
Disaccharide Exposure and Mobility labiose is compatible with antibody binding of small
The galabiose disaccharide is 71% exposed to solvent in haptens and therefore supports the likelihood of HggP6
the crystal structure. The orientation adopted by HggP6 conformations that fully expose the carbohydrates (e.g.,
places most of its mass into the open space between Figure 3C).
the a1a2 helices. Thus, the overall exposed surface area
of the glycopeptide is substantially greater than that of
Carbohydrate Dominance of the TCR Footprintnormal peptides bound by Kb and other MHC I antigens
An extended glycan linker, such as that observed in the(see Figures 3D and 3E). Contact between glycopeptide
RGY8-6H-Gal2 crystal structure, will place the galabioseresidue HggP6 and the a2 helix also contributes to signif-
well above the peptide backbone in the pMHC regionicantly more Kb-buried surface in the glycopeptide com-
plex (952 AÊ 2) than in Kb/VSV-8 (843 AÊ 2). normally covered by the a/b TCR CDR3 loops (Garboczi
Immunity
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Figure 3. The H-2Kb Glycopeptide Complex
Structure and Comparison with Other MHC
I±Bound Peptides and Modeled Glycopep-
tides
(A) The Kb/RGY8-6H-Gal2 crystal structure
showing the glycopeptide colored by atom
type (see Figure 2) and MHC a1a2 superdo-
main (residues 1±180) in light gray viewed
from the side and (B) along the peptide bind-
ing groove. (C) A model derived from the crys-
tal structure in which only very small rotations
about the HggP6 linker torsion angles dra-
matically change the level of TCR access to
the carbohydrate (compare to B). (D) The
greater size and exposure of the carbohy-
drate component of RGY8-6H-Gal2 shown in
comparison with other MHC I peptide ligands
(the PDB accession codes and references are
given in Experimental Procedures). The su-
perpostions are the result of aligning only the
Ca atoms of the MHC a1a2 domains and then
comparing the positions of the bound pep-
tides. RGY8-6H-Gal2 is yellow. The other hu-
man MHC I bound peptides are: purple, HLA-
A2/Influenza M1; cyan, HLA-B8/HIV1 GAG 7r;
green, HLA-B53/HIV2 GAG; and pink, HLA-
B35/HIV1 NEF. (E) A similar comparison of
RGY8-6H-Gal2 (yellow) with other murine
MHC I bound peptides: red, Ld/QL9; magenta,
Db/Infl NP; and light green, Kb/SEV-9. (F) A
model of Db-bound ASN9-6H-Gal2 superim-
posed with RGY8-6H-Gal2.
et al., 1996; Garcia et al., 1996, 1998; Ding et al., 1998). induced through TCR binding. A great variety of TCR
docking scenarios and HggP6 conformations appearTorsion angle rotations of the linker can result in large
lateral movements of the galabiose; however, the central feasible, and could potentially coexist in vivo, which
would explain the simultaneous generation of carbohy-peptide attachment site, combined with the diagonal
orientation of the TCR over the MHC binding groove, drate-specific g/d CTL and glycopeptide-specific a/b
CTL by RGY8-6H-Gal2.still keeps the galabiose within the CDR3 region of the
TCR footprint. Therefore, direct interactions between
the RGY8-6H-Gal2 carbohydrates and the TCR CDR3 Discussion
loops are relatively convincing.
The current position of the disaccharide in the Important Structural Features of the
Kb/Glycopeptide ComplexKb/RGY8-6H-Gal2 crystal structure would place it under
the CDR3b loop and next to a key b chain contact patch The crystal structure of H-2Kb-bound RGY8-6H-Gal2 re-
veals the VSV-8 carrier peptide and Kb structures areon the MHC a2 helix (residues 149±158). TCR recognition
of the galabiose, therefore, would predominantly involve unaffected by the peptide glycosylation; thus, the novel
features of the glycopeptide presentation are specifi-the b subunit. The area between the glycopeptide and
the a1 helix is more accessible and could allow TCR a cally localized to the carbohydrate portion of the ligand.
Indeed, the glycan modification places the galabioseand b subunit contacts directly to the peptide backbone
as well as to the side chains. TCR corecognition of disaccharide at the outer limits of the MHC peptide bind-
ing groove where it abuts the apex of the a2 helix, wellglycopeptide and MHC residues in this manner favors
an MHC-restricted, glycopeptide-specific a/b T cell re- beyond the reach of normal peptide side chains. The
galabiose is secured at this position more by intermolec-sponse, and may explain the low-level bulk CTL cross-
reactivity to the carrier peptide stripped of carbohy- ular crystal contacts to a neighboring b2m molecule than
by intramolecular contacts to the MHC receptor, sug-drate.
The highly exposed galabiose also closely matches gesting that HggP6 may have significantly more confor-
mational freedom in solution.the attributes of preferred g/d T cell antigens that sup-
ports the dichotomy of the anti-RGY8-6H-Gal2 T cell The chemical structure, P6 substitution site, and size
of the Hgg linker favor a highly exposed hapten moietyresponse. Direct, immunoglobin-like recognition of the
galabiose, either as a highly exposed glycopeptide hap- in virtually any linker conformation. This unusual access
to an MHC I bound ligand allows for direct TCR interac-ten or glycolipid headgroup, is easily conceivable. Com-
plete carbohydrate exposure can be achieved by varying tions with the galabiose, which is considerably larger
than an amino acid side chain. Alterations in the shapethe HggP6 conformation (e.g., Figure 3C) or may be
Structure of an MHC-Glycopeptide Complex
57
Figure 4. The Proposed Relationship between Peptide Glycan Structure and Specfic TCR Recognition
In this model, the a/b TCR simultaneously binds the MHC, peptide, and glycan, whereas the g/d TCR binds only the glycan. The highest
positions reached by the MHC a1 and a2 helices are represented by the helical ribbons in the background. The glycans are assumed to be
substituted for single, central, and outward pointing peptide residues and to have nearly fully extended conformations. The glycans shown
represent (from left to right) H-galabiose, H-CD77, and H-GM3-lactam on a Kb bound 8-mer, and H-galabiose and H-CD77 on a Db-bound
9-mer (see Figure 1). The extent of exposure (vertical axis) is correlated with generation of reactive CTL (horizontal axis) as outlined in Table
1 and Abdel-Motal et al. (1996). Note that high glycan exposure does not necessarily guarantee good immunogenicity since a/b TCR
corecognition of the pMHC is disfavored and the glycan is less likely to have a defined antigenic structure outside of the MHC binding groove
suitable for g/d TCR recognition.
of the TCR combining site, such as large conformational now apparent that glycans at these positions would not
promote contact between carbohydate haptens and theadjustments of the CDR3 loops, may be required for a
TCR to bind the Kb/RGY8-6H-Gal2 disaccharide com- hypervariable CDR3 loops of an a/b TCR, leading to the
killing of both carrier peptide and glycopeptide coatedpared to a pMHC. Movements of up to several ang-
stroms by CDRs 1a, 3a, and 3b were observed in com- target cells by the CTL generated against glycopeptides
with noncentral glycan modifications (Ishioka et al.,parisons between the free and bound structures of the
murine 2C TCR (Garcia et al., 1998). It is likely that CDR 1992; Abdel-Motal et al., 1996; Kihlberg and Elofsson,
1997).flexibility is also involved, although to a lesser extent,
in the high-affinity allorecognition of the H-2Ld/QL9 pep- Glycosylation of the central peptide residues places
the carbohydrates within the expected TCR CDR3a andtide complex by the 2C TCR. A model of the 2C/Ld inter-
action (Speir et al., 1998) reveals that a bulge near the 3b footprint and yields glycopeptides whose immunoge-
nicity is dependent upon the linker length and carbohy-QL9 C terminus, as a result of a ridge in the Ld binding
groove floor, is likely to greatly increase the TCR contact drate size. Glycopeptides incorporating disaccharides
or larger carbohydrates linked to serine showed weakwith the QL9 peptide and require different conforma-
tions of the 2C CDRs for optimal binding compared to CTL immunogenicity, as well as poor detection by car-
bohydrate-specific MAb on the cell surface (Abdel-the syngeneic 2C/dEV8/Kb complex. Alternatively, HggP6
may adopt a conformation that places the carbohydrate Motal et al., 1996). In contrast, GlcNAc monosaccha-
rides coupled to peptides with serine linkers generateinto a cavity between the TCR a and b chains (Garcia
et al., 1996) or generally between the TCR and pMHC, CTL that are able to discriminate between the glycosy-
lated and native peptides, as well as between chemicallyrequiring little to no structural adjustments of either re-
ceptor. Indeed, the TCR-pMHC interfaces are extensive similar glycopeptides (Haurum et al., 1994). The fine
but exhibit poor shape complementarity, leaving large specificity demonstrated in T cell recognition of the
cavities between the contacting surfaces (Garboczi et GlcNAc-based glycopeptides suggests monosaccha-
al., 1996; Ding et al., 1998; Garcia et al., 1998). Regard- rides attached to short linkers near the peptide center
less of the poorly formed TCR-pMHC interface, central are better suited for glycopeptide-specific a/b TCR rec-
modifications of the peptide antigen that extend out- ognition. From the Kb/RGY8-6H-Gal2 structure, it ap-
ward from the MHC binding groove will create new and pears the greater mass of the serine-linked disaccha-
more numerous contacts with the TCR. rides and larger carbohydrates will be confined to the
limited space between the MHC helices and thus may
interfere with TCR-MHC interactions and/or hinder spe-Glycopeptide Structure-Function
Relationships: A Beginning cific-recognition of the carbohydrates by the TCR. The
smaller size of monosaccharides is less likely to disruptMHC I and II bound peptide immunogens with glycosyla-
tion sites outside of the central peptide residues nor- a/b TCR interactions within the MHC binding site, but
their relatively low exposure disfavors a carbohydrate-mally fail to generate glycopeptide-specific CTL (Abdel-
Motal et al., 1996; Kihlberg and Elofsson, 1997). It is specific g/d T cell response (Figure 4).
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Longer oligosaccharide tethers, such as homocys- Less exposed oligosaccharides may also be capable
of generating g/d CTL, but peptide and MHC residuesteine, can fully expose bound carbohydrates (Figures 3
and 4). The greater exposure results in facilitated MAb are more likely to be in close proximity to these carbohy-
drates and may inhibit g/d TCR binding. Interestingly,detection of the sugars and strong generation of carbo-
hydrate-specific CTL (Abdel-Motal et al., 1996), presum- the inherent linker flexibility of HggP6 in RGY8-6H-Gal2
may provide the glycan with the ability to switch be-ably through direct interaction between TCRs and the
carbohydrates. Furthermore, the unobstructed access tween the positions and/or structures best recognized
by the two types of TCR, providing a rationale for theto the glycan is probably a key factor in generating an
MHC-unrestricted g/d T cell response. Several cross- concurrent generation of glycopeptide-specific a/b CTL
and carbohydrate-specific g/d CTL.reactive T cell clones to MHC bound peptides with chemi-
cally TNP-modified lysine residues have been described
(Martin et al., 1992). TNP exposure, when attached to
Implications for T Cell Recognitionlysine, would be equivalent to that of homocysteine-
of Natural Glycopeptideslinked galabiose, and could be responsible for the immu-
Glycosylation of secreted, cell surface, nuclear, andnodominance of the TNP epitopes and restriction of the
cytoplasmic proteins (Hart et al., 1989) is a commonresponding T cell repertoire (Hochgeschwender et al.,
posttranslational modification that plays a crucial role1987). Furthermore, the specificity of the cross-reactive
in molecular structure and stability, masking of microor-T cells only for TNP-lysine located near the center of
ganism target epitopes, and modulation of specific pro-the peptide, and the freedom of one TNP-specific T
tein functions (Varki, 1993). The small number of naturalcell hybridoma from class II polymophism, mirrors the
MHC I bound glycopeptides that have been identifiedbehavior of carbohydrate-specific CTL (Martin et al.,
may reflect their limited numbers at the cell surface or1992; Kohler et al., 1997). Thus, central placement and
the technical difficulties in their detection (Haurum etextensive exposure are common factors in MHC anti-
al., 1994), but not necessarily their importance in thegens that produce enhanced cross-reactivity, reduced
cellular immune response since T cell avidity for pMHCMHC restriction, and hapten-specfic recognition by the
antigens widely varies. Our results, together with thoseresponding T cell population.
from other studies of glycopeptide immunogenicity,
suggest small carbohydrates (mono or disaccharides)
Poor or Diminished CTL Reactivity to Large attached to short, centrally placed linkers satisfy a/b
Oligosaccharides and Db-Bound Galabiose TCR antigen binding preferences, and that carbohy-
Db-bound glycopeptides with homocysteine linked ga- drates of the same size attached to slightly longer linkers
labiose (e.g., Figure 3F) are poorly immunogenic, and may also satisfy the requirements for g/d TCR antigen
Kb-bound glycopeptides presenting homocysteine-linked binding (Figure 4), leading to glycopeptide and carbohy-
CD77 or GM3-lactam are less immunogenic than RGY8- drate-specific T cell responses. Asparagine-linked gly-
6H-Gal2 (Table 1; Abdel-Motal et al., 1996). Interestingly, cans have a pentasaccharide core decorated by further
these glycopeptide designs could place carbohydrate carbohydrate additions (Kornfeld and Kornfeld, 1985);
structures further above the MHC a1a2 helices than ob- therefore, the corresponding glycopeptides would not
served in Kb/RGY8-6H-Gal2 (Figure 4), as CD77 and be well suited for carbohydrate-specific CTL. In con-
GM3-lactam are larger than galabiose by one sugar unit trast, many mucins and other O-linked glycoconjugates
or more. In addition, the Db-binding glycopeptides have found in the cytoplasm and nucleus are composed of
a large arch in the peptide backbone near the C terminus mono- or disaccharides attached to serine, threonine,
that would futher elevate glycans attached to the bulged hydroxylysine or tyrosine (Hart et al., 1989; Kihlberg and
residues (Figures 3F and 4; Young et al., 1994). Elofsson, 1997) and, therefore, are more promising natu-
Peptide antigen recognition by a/b TCR normally oc- ral glycan antigens for T cells. The mucins, that include
curs within the a1a2 helices and may, therefore, fail to the Tn and sialyl Tn epitopes that are present on cancer
entirely encompass these large glycans. Furthermore, cells and HIV envelope glycoprotein gp120 (Hansen et
carbohydrates outside or atop the a1a2 helices are likely al., 1990), can be recognized by T cells (Galli-Stampino
to disrupt conserved TCR-MHC interactions that are et al., 1997). Carbohydrate structures that are not well
important to the docking, orientation, and proper regis- represented or are poorly immunogenic in normal anti-
ter of the TCR on the pMHC molecule and hence can gen presentation could also be used in synthetic peptide
explain the reduced, poor, or lack of CTL reactivity to immunogens to activate defined, carbohydrate-specific
these glycopeptides (Table 1). T cell populations. The ability to generate or enhance
the Ig-like, MHC-unrestricted g/d T cell responses to the
glycopeptide could further augment T cell surveillanceg/d T Cell Response to Glycolipid
The Kb/RGY8-6H-Gal2 crystal structure supports the and CTL effector functions against cells presenting the
corresponding carbohydrate hapten. Indeed, peptide-possibility of distinct g/d CTL stimulation through MHC-
unrestricted g/d TCR recognition of the exposed carbo- based vaccines able to generate carbohydrate-specific
CTL have potential clinical applications for treatmenthydrate haptens. Indeed, the g/d T cells may be directly
triggered by corresponding galabiose-presenting glyco- of various types of cancer and parasitic infections (Lan-
zavecchia, 1993; Chesnut et al., 1995) by targeting ab-lipids fused with target cells (Abdel-Motal et al., 1996).
However, it is unknown whether MHC-unrestricted anti- normal glycosylation produced by malignant cells or
oligosaccharide structures unique to microorganismsgen binding by g/d TCR allows triggering and clonal
expansion of g/d CTL in the present system. (Kaufmann, 1996).
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Experimental Procedures
Table 3. X-Ray Data Processing and Refinement Statistics for
the H-2Kb Glycopeptide ComplexCarbohydrates, Glycopeptides, and Glycolipids
Galabiose (Gal-a(1,4)Gal-b or Gal2), CD77 (Gal-a(1,4)Gal-b(1,4)Glc-b), Data Processing
lactose (Gal-b(1,4)-Glc-b), GM3 (NeuAc-a(3)-GalN-b(1,4)Glc-b), and
(All Data) (Outer Shell)GM3-lactam were synthesized as described (Figure 1; Abdel-Motal
Resolution range (AÊ ) 20±2.1 2.17±2.1et al., 1995; Kihlberg and Elofsson, 1997). Monoclonal antibodies
Unique Reflections 28511 1734specific for the carbohydrates were used to test the expression of
Completeness (%) 89.3 55.0carbohydrates on the surface of glycopeptide-treated RMA-S cells
Rmerge (%)a 7.8 38.4(Abdel-Motal et al., 1996).
Average I/s1 16.2 1.9Glycopeptides and glycolipids were synthesized and tested for
Redundancyb 5.4 1.7Kb and Db-binding capacity, carbohydrate presentation, and stability
in vivo as described (Abdel-Motal et al., 1995, 1996). Refinementc
Resolution range (AÊ ) 18±2.2 2.3±2.2CTL Generation, Assay, and Fractionation
Rcrystd (no. of refls) 0.224 (23515) 0.368 (2374)CTL were generated by immunization of C57BL/6 mice with 100 mg
Rfreed (no. of refls) 0.279 (2605) 0.422 (266)glycopeptide in Freund's incomplete adjuvant at the base of the
Number of atomse (Ca atoms) 3304 (381)tail followed by in vitro restimulation of harvested spleen cells, as
Water molecules: 108 N-linked carbohydrates: 4described (Zhou et al., 1992). CTL were tested in a short-term 4
Coordinate errorf: 0.38AÊ Real space CCg: 0.90hr 51Cr-release assay against peptide-, glycopeptide- or glycolipid-
treated target cells. Glycolipid-expressing target cells were pro- Protein Geometry and Thermal Parameters
duced by treatment of target cells with liposomes containing the
R.m.s. deviation from ideality: Ramachandram Plot:different glycolipids as described (Abdel-Motal et al., 1995). CTL
bonds 0.008AÊ favored 89.2%populations were fractionated using either anti-a/b or g/d framework
angles 1.48 allowed 10.2%MAb on magnetic Dynabeads (Dynal A. S., Norway).
dihedrals 26.28 generous 0.6%
impropers 1.38 disallowed 0%Preparation and Crystallization of the
Average B-values (AÊ 2):Kb-Glycopeptide Complex
all atoms 31 carbohydrates 58Purified H-2Kb was incubated with a 5-fold molar excess of RGY8-
peptide 35 waters 376H-Gal2 for 5 hr at room temperature (see Stura et al., 1992). Centri-
con 10 ultrafiltration was used to concentrate the MHC complex The space group is P21212 with one molecule per asymmetric unit.
and clear any free peptide simultaneously. An exchange of bound The unit cell dimensions are a 5 135.9 AÊ , b 5 86.8 AÊ , c 5 45.0 AÊ .
peptides was apparent from notable band shifts between treated a Rmerge 5 (ShSi (Ihi 2 ,Ih.)/ShSi Ih) 3 100 where ,Ih. is the mean of
and untreated samples subjected to IEF electrophoresis (data not the Ihi observations of reflection h.
shown; see also Stura et al., 1992). Large single crystals were grown b Redundancy 5 , # of observations / # of unique reflections ..
from 18 mg/ml H-2Kb in 2.3 M Na/K PO4, 2% 2-methyl-2,4-pentane- c Statistics for all data with F/sF $ 0.
diol (pH 6.4), with diffraction to approximately 2.0 AÊ resolution. d Rcryst 5 (Sh|Fo 2 Fc| / ShFo) where Fo and Fc are the observed and
calculated structure factors; Rfree is Rcryst computed with only the test
Data Collection and Processing set structure factors.
Diffraction data were collected in house from a flash-cooled (130 e Number for all non-hydrogen atoms, including the waters and car-
K, 25% glycerol) single crystal (0.5 3 0.5 3 0.3 mm) with a 30 cm MAR bohydrates.
image plate mounted on a Siemens M18X CuKa x-ray generator (300 f Estimated from cross-validated Luzzati plots (Luzzati, 1952) using
mm focal cup, 50 kV, 80 mA) fitted with Supper long double-mirror a low resolution limit of 5 AÊ .
focusing optics. The data were indexed and integrated with the g Correlation coefficient (CC) computed for all protein atoms with
program DENZO (Otwinowski and Minor, 1997). The crystals are program O (Jones et al., 1991).
orthorhombic, P21212, with unit cell dimensions a 5 135.9 AÊ , b 5
86.8 AÊ , and c 5 45.0 AÊ . The Vm (Matthews, 1968) of 2.86 AÊ 3 Da21
indicated one molecule per asymmetric unit with a solvent content probably due to limited data completeness; therefore, the high reso-
of 57%. The data were merged, scaled, and reduced to a unique lution limit was reduced to 2.2 AÊ (Table 3). The coordinates and
reflection set using the program SCALEPACK (Table 3; Otwinowski reflection data (keeping the same Rfree data partition) were converted
and Minor, 1997). for use in the SHELXL automated water divining routine (Sheldrick
and Schneider, 1997) and 108 waters were retained after manual
inspection. The final rounds of positional and B-value refinement inModel Refinement
A random set of 10% of the reflections between 18±2.1 AÊ were X-PLOR gave an Rcryst of 22.4% and an Rfree of 27.9% (Table 3).
excluded from refinement to monitor Rfree (BruÈ nger, 1997). Only pro-
cedures that minimized both Rcryst and Rfree were utilized. Kb/VSV-8 Structural Analysis and Illustrations
The H-2Kb glycopeptide structure was compared with othercoordinates (Fremont et al., 1992) stripped of peptide were directly
refined against the glycopeptide data using X-PLOR v3.851 (BruÈ nger Kb/peptide complexes (PDB accession codes 2VAA, 2VAB; Fremont
et al., 1992), the H-2Db/peptide complex (1HOC, Young et al., 1994),et al., 1987). Rigid body refinement from 8±2.1 AÊ resolution (F/sF . 2)
gave an Rcryst of 36.6% and an Rfree of 35.7%. One round of refinement, the H-2Ld/peptide complex (1LDP, Speir et al., 1998), the HLA-A2/
Influenza M1 peptide complex (1HHI, Madden et al., 1993), andbulk-solvent correction, and model rebuilding was performed using
positional minimization and iterative slow-cooled molecular dynam- various complexes of HIV-derived peptides bound to HLA molecules
B35, B53, and B8 (1AGE, Reid et al., 1996; 1A1M, Smith et al., 1996a;ics as implemented in X-PLOR (serial slow cool, Kleywegt and
Jones, 1997) before the peptide was traced (Rcryst 27.5%, Rfree 32.5%). 1A1N, Smith et al., 1996b). PROCHECK (Laskowski et al., 1993)
was used to examine polypeptide geometry, PROMOTIF to identify3Fo-2Fc, 2Fo-Fc shake omit (McRee, 1993), and shaken, sA-weighted
(Read, 1986) 2Fo-Fc and Fo-Fc electron density maps were computed secondary structure elements (Hutchinson and Thornton, 1996),
CONTACSYM (Sheriff et al., 1987) to identify van der Waals contactsto reduce phase bias for model rebuilding. Strong density in shaken,
sA-weighted Fo-Fc maps was located within the peptide binding up to 4 AÊ apart, and HBPLUS (McDonald and Thornton, 1994) to
locate hydrogen bond pairs using both distance and geometry crite-groove and included the entire glycosylated homocysteine at posi-
tion six (HggP6; Figure 2). HggP6 was constructed with the help of ria. Buried surface areas were computed with MS (Connolly, 1983)
using a 1.4 AÊ radius probe. Figure 2 was created using programsthe hetero-compound libraries (e.g., homocysteine and galactose)
provided by G. Kleywegt's web site (http://alpha2.bmc.uu.se/hicup; O (Jones et al., 1991) and MolView (Smith, 1995). Figure 3 was
created using MIDAS (Ferrin et al., 1988).Kleywegt, 1995). The Rfree for the outer reflection bin failed to decline,
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